Eyenovia(EYEN)
搜索文档
Eyenovia(EYEN) - 2020 Q3 - Quarterly Report
2020-11-13 05:05
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 Par Value EYEN Nasdaq Capital Market FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2020 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to ______ ...
Eyenovia(EYEN) - 2020 Q3 - Earnings Call Transcript
2020-11-11 11:01
Eyenovia, Inc. (NASDAQ:EYEN) Q3 2020 Earnings Conference Call November 10, 2020 4:30 PM ET Company Participants Eric Ribner - IR Sean Ianchulev - CEO and Chief Medical Officer John Gandolfo - CFO Michael Rowe - VP, Commercial Conference Call Participants Boobalan Pachaiyappan - H.C. Wainwright Matt Kaplan - Ladenburg Thalmann Jonathan Aschoff - ROTH Capital Partners Leonard Yaffe - Stoc*Doc Partners Operator Greetings, and welcome to Eyenovia's Third Quarter 2020 Earnings Call. At this time, all participant ...
Eyenovia(EYEN) - 2020 Q2 - Quarterly Report
2020-08-15 02:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 Par Value EYEN Nasdaq Capital Market FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2020 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to ___________ ...
Eyenovia(EYEN) - 2020 Q2 - Earnings Call Transcript
2020-08-13 11:05
Eyenovia, Inc. (NASDAQ:EYEN) Q2 2020 Earnings Conference Call August 12, 2020 4:30 PM ET Company Participants Alexander Lobo - The Ruth Group Sean Ianchulev - Chief Executive Officer & Chief Medical Officer Michael Rowe - Vice President, Commercial John Gandolfo - Chief Financial Officer Conference Call Participants Matt Kaplan - Ladenburg Thalmann Blair Cohen - H.C. Wainwright & Co. Michael Brcic - National Securities Leonard Yaffe - Stoc*Doc Partners, L.P Operator Ladies and gentlemen, thank you for stand ...
Eyenovia(EYEN) - 2020 Q1 - Quarterly Report
2020-05-15 01:10
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 Par Value EYEN Nasdaq Capital Market FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2020 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to __________ ...
Eyenovia(EYEN) - 2020 Q1 - Earnings Call Transcript
2020-05-14 12:38
Eyenovia, Inc. (NASDAQ:EYEN) Q1 2020 Earnings Conference Call May 13, 2020 4:45 PM ET Company Participants Tram Bui - Senior Vice President, Investor Relations Sean Ianchulev - Chief Executive Officer & Chief Medical Officer Michael Rowe - Vice President, Commercial John Gandolfo - Chief Financial Officer Conference Call Participants Matt Kaplan - Ladenburg Thalmann Yi Chen - H.C. Wainwright & Co. Jonathan Aschoff - ROTH Capital Partners Operator Ladies and gentlemen, thank you for standing by. And welcome ...
Eyenovia(EYEN) - 2019 Q4 - Annual Report
2020-03-31 00:10
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to ______________________ COMMISSION FILE NUMBER: 001-38365 | --- | --- | |----------------------------------------------------------------------------|----- ...
Eyenovia(EYEN) - 2019 Q4 - Earnings Call Transcript
2020-03-26 09:16
Eyenovia, Inc. (NASDAQ:EYEN) Q4 2019 Earnings Conference Call March 25, 2020 4:30 PM ET Company Participants Alexander Lobo - The Ruth Group Sean Ianchulev - Chief Executive Officer and Chief Medical Officer Michael Rowe - Vice President of Commercial John Gandolfo - Chief Financial Officer Conference Call Participants Matt Kaplan - Ladenburg Thalmann Jonathan Aschoff - ROTH Capital Partners Esther Rajavelu - Oppenheimer & Co. Yi Chen - H.C. Wainwright & Co. Maria Barbera - National Securities * Operator La ...
Eyenovia (EYEN) Investor Presentation - Slideshow
2020-03-19 02:28
Making it Possible March 2020 Forward-Looking Statements 1 Except for historical information, all of the statements, expectations, and assumptions contained in this presentation are forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions, including estimated market opportunities in the United Stat ...
Eyenovia(EYEN) - 2019 Q3 - Quarterly Report
2019-11-14 05:24
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 Par Value EYEN Nasdaq Capital Market FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to ______ ...